Follow
Asma Naseem
Asma Naseem
Verified email at ucl.ac.uk
Title
Cited by
Cited by
Year
Serpin inhibition mechanism: a delicate balance between native metastable state and polymerization
MS Khan, P Singh, A Azhar, A Naseem, Q Rashid, MA Kabir, ...
Journal of amino acids 2011, 2011
1072011
Laser therapy inhibits tumor growth in mice by promoting immune surveillance and vessel normalization
G Ottaviani, V Martinelli, K Rupel, N Caronni, A Naseem, L Zandonà, ...
EBioMedicine 11, 165-172, 2016
672016
Cellular TRIM33 restrains HIV-1 infection by targeting viral integrase for proteasomal degradation
H Ali, M Mano, L Braga, A Naseem, B Marini, DM Vu, C Collesi, G Meroni, ...
Nature communications 10 (1), 926, 2019
492019
Neutrophils drive type I interferon production and autoantibodies in patients with Wiskott-Aldrich syndrome
KE Cervantes-Luevano, N Caronni, MC Castiello, E Fontana, GM Piperno, ...
Journal of Allergy and Clinical Immunology 142 (5), 1605-1617. e4, 2018
212018
Antiangiogenic function of antithrombin is dependent on its conformational variation: implication for other serpins
A Azhar, P Singh, Q Rashid, A Naseem, M Sazzad Khan, ...
Protein and Peptide Letters 20 (4), 403-411, 2013
212013
Wiskott-Aldrich syndrome protein restricts cGAS/STING activation by dsDNA immune complexes
GM Piperno, A Naseem, G Silvestrelli, R Amadio, N Caronni, ...
JCI insight 5 (17), 2020
132020
Elucidating the specificity of non-heparin-based conformational activators of antithrombin for factor Xa inhibition
Q Rashid, M Abid, MA Jairajpuri
Journal of Natural Science, Biology, and Medicine 5 (1), 36, 2014
122014
Catechol biodegradation by Pseudomonas strain: a critical analysis
M Zeyaullah, R Ahmad, A Naseem, B Islam, HMI Hasan, AS Abdelkafe, ...
Int. J. Chem. Sci 7 (3), 2211-2221, 2009
122009
Deciphering the role of trehalose in hindering antithrombin polymerization
A Naseem, MS Khan, H Ali, I Ahmad, MA Jairajpuri
Bioscience Reports 39 (4), BSR20182259, 2019
92019
Oxidized antithrombin is a dual inhibitor of coagulation and angiogenesis: importance of low heparin affinity
A Azhar, MS Khan, A Swaminathan, A Naseem, S Chatterjee, ...
International journal of biological macromolecules 82, 541-550, 2016
92016
Genome editing for primary immunodeficiencies: A therapeutic perspective on Wiskott-Aldrich syndrome
A Naseem, Z Steinberg, A Cavazza
Frontiers in Immunology 13, 966084, 2022
72022
An improved medium formulation for efficient ex vivo gene editing, expansion and engraftment of hematopoietic stem and progenitor cells
R Rai, A Naseem, W Vetharoy, Z Steinberg, AJ Thrasher, G Santilli, ...
Molecular Therapy-Methods & Clinical Development 29, 58-69, 2023
52023
Analysis of surface cavity in serpin family reveals potential binding sites for chemical chaperone to reduce polymerization
P Singh, MS Khan, A Naseem, MA Jairajpuri
Journal of molecular modeling 18, 1143-1151, 2012
42012
Optimized cell culture conditions promote ex-vivo manipulation and expansion of primitive hematopoietic stem cells for therapeutic gene editing
R Rai, W Vetharoy, A Naseem, Z Steinberg, AJ Thrasher, G Santilli, ...
bioRxiv, 2022.01. 11.475795, 2022
22022
Multidimensional Response Surface Methodology for the Development of a Gene Editing Protocol for p67phox-Deficient Chronic Granulomatous Disease
TE Whittaker, SE Moula, S Bahal, FG Bakri, WA Hayajneh, AK Daoud, ...
Human Gene Therapy, 2024
12024
SARS-CoV-2 Syncytium under the radar: molecular insights of the spike-induced syncytia and potential strategies to limit SARS-CoV-2 replication
H Ali, A Naseem, ZI Siddiqui
Journal of Clinical Medicine 12 (18), 6079, 2023
12023
Preclinical Safety and Feasibility Study of a CRISPR/Cas9 Gene Editing Platform to Treat Wiskott Aldrich Syndrome
A Naseem, R Rai, G Turchiano, T Whittaker, AJ Thrasher, A Cavazza
MOLECULAR THERAPY 30 (4), 34-34, 2022
12022
Preclinical studies for a hematopoietic stem cell gene editing platform to treat Wiskott-Aldrich Syndrome.
A Naseem, W Vetharoy, R Rai, TE Whittaker, G Turchiano, AJ Thrasher, ...
HUMAN GENE THERAPY 32 (19-20), A72-A72, 2021
12021
It’s all about location: Targeting the right spot for Wiskott-Aldrich syndrome
A Naseem, A Cavazza
Molecular Therapy Methods & Clinical Development 32 (2), 2024
2024
Hematopoietic stem cell gene editing rescues B-cell development in X-linked agammaglobulinemia
S Bahal, M Zinicola, SE Moula, TE Whittaker, A Schejtman, A Naseem, ...
Journal of Allergy and Clinical Immunology, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20